Simultaneous imaging and restoration of cell function using cell permeable peptide probe

Biomaterials

Volumn 35, Issue 24, 2014, Pages 6287-6298

  Suh, Jin Sook ^a   Lee, Jue Yeon ^b   Lee, Gene ^a   Chung, Chong Pyoung ^b   Park, Yoon Jeong ^a,b  

^a Seoul National University   (South Korea)

^b Nano Intelligent Biomedical Engineering Corporation (NIBEC)   (South Korea)

Author keywords

Cell penetrating peptide probe; Osteogenesis; Stem cell monitoring; Theranosis; Ubiquitin proteasomal system

Indexed keywords

BINDING ENERGY; BIOCHEMISTRY; CYTOLOGY; DIAGNOSIS; DISEASES; FLUORESCENCE; FLUOROPHORES; GENE EXPRESSION; PHOSPHATASES; PROBES; STEM CELLS;

CELL MONITORING; CELL-PENETRATING PEPTIDE; OSTEOGENESIS; THERANOSIS; UBIQUITIN-PROTEASOMAL SYSTEM;

PEPTIDES;

CELL PENETRATING PEPTIDE; FLUORESCENT DYE; MOLECULAR PROBE; SMAD PROTEIN; SMURF1 PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

AMINO ACID SEQUENCE; ANIMAL; BIOLOGICAL MODEL; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; ENDOCYTOSIS; FEMALE; HUMAN; KINETICS; LEWIS RAT; MESENCHYMAL STROMA CELL; METABOLISM; MOLECULAR GENETICS; MOLECULAR IMAGING; MOLECULAR PROBE; PATHOLOGY; PHARMACOLOGY; RHEUMATIC FEVER; UBIQUITINATION;

AMINO ACID SEQUENCE; ANIMALS; CELL DIFFERENTIATION; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CELL-PENETRATING PEPTIDES; DISEASE MODELS, ANIMAL; ENDOCYTOSIS; FEMALE; FLUORESCENT DYES; HUMANS; KINETICS; MESENCHYMAL STROMAL CELLS; MODELS, BIOLOGICAL; MOLECULAR IMAGING; MOLECULAR PROBES; MOLECULAR SEQUENCE DATA; OSTEOGENESIS; RATS, INBRED LEW; RHEUMATIC FEVER; SMAD PROTEINS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84901424244     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.04.045     Document Type: Article

References (41)

1. Kim E.M., Park E.H., Cheong S.J., Lee C.M., Kim D.W., Jeong H.J., et al. Characterization, biodistribution and small-animal SPECT of I-125-labeled c-Met binding peptide in mice bearing c-Met receptor tyrosine kinase-positive tumor xenografts. Nucl Med Biol 2009, 36:371-378.
2. Czernin J., Weber W.A., Herschman H.R. Molecular imaging in the development of cancer therapeutics. Annu Rev Med 2006, 57:99-118.
3. Blanco-Mezquita T., Martinez-Garcia C., Proenca R., Zieske J.D., Bonini S., Lambiase A., et al. Nerve growth factor promotes corneal epithelial migration by enhancing expression of matrix metalloprotease-9. Invest Ophthalmol Vis Sci 2013, 54:3880-3890.
4. Zhou Q., Gil-Krzewska A., Peruzzi G., Borrego F. Matrix metalloproteinases inhibition promotes the polyfunctionality of human natural killer cells in therapeutic antibody-based anti-tumour immunotherapy. Clin Exp Immunol 2013, 173:131-139.
5. Akhatib B., Onnerfjord P., Gawri R., Ouellet J., Jarzem P., Heinegard D., et al. Chondroadherin fragmentation mediated by the protease HTRA1 distinguishes human intervertebral disc degeneration from normal aging. JBiol Chem 2013, 288:19280-19287.
6. Ryu J.H., Lee A., Chu J.U., Koo H., Ko C.Y., Kim H.S., et al. Early diagnosis of arthritis in mice with collagen-induced arthritis, using a fluorogenic matrix metalloproteinase 3-specific polymeric probe. Arthritis Rheum 2011, 63:3824-3832.
7. Marquez B.V., Beck H.E., Aweda T.A., Phinney B., Holsclaw C., Jewell W., et al. Enhancing peptide ligand binding to vascular endothelial growth factor by covalent bond formation. Bioconjug Chem 2012, 16:1080-1089.
8. Ehrlich A., Ray P., Luker K.E., Lolis E.J., Luker G.D. Allosteric peptide regulators ofchemokine receptors CXCR4 and CXCR7. Biochem Pharmacol 2013, 86:1263-1271.
9. Tian M., Xie Q. Non-26S proteasome proteolytic role of ubiquitin in plant endocytosis and endosomal trafficking(F). JIntegr Plant Biol 2013, 55:54-63.
10. Schulman B.A., Harper J.W. Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways. Nat Rev Mol Cell Biol 2009, 10:319-331.
11. Ye Y., Rape M. Building ubiquitin chains: E2 enzymes at work. Nat Rev Mol Cell Biol 2009, 10:755-764.
12. Wang Z., Nie Z., Chen W., Zhou Z., Kong Q., Seth A.K., et al. RNF115/BCA2 E3 ubiquitin ligase promotes breast cancer cell proliferation through targeting p21(Waf1/Cip1) for ubiquitin-mediated degradation. Neoplasia 2013, 15:1028-1035.
13. Schnetzke U., Fischer M., Spies-Weisshart B., Zirm E., Hochhaus A., Muller J.P., et al. The E3 ubiquitin ligase TRAF2 can contribute to TNF-alpha resistance in FLT3-ITD-positive AML cells. Leuk Res 2013, 37:1557-1564.
14. Pan W.W., Zhou J.J., Yu C., Xu Y., Guo L.J., Zhang H.Y., et al. Ubiquitin E3 ligase CRL4(CDT2/DCAF2) as a potential chemotherapeutic target for ovarian surface epithelial cancer. JBiol Chem 2013, 288:29680-29691.
15. Sangadala S., Boden S.D., Viggeswarapu M., Liu Y., Titus L. LIM mineralization protein-1 potentiates bone morphogenetic protein responsiveness via a novel interaction with Smurf1 resulting in decreased ubiquitination of Smads. JBiol Chem 2006, 281:17212-17219.
16. Boden S.D., Liu Y., Hair G.A., Helms J.A., Hu D., Racine M., et al. LMP-1, a LIM-domain protein, mediates BMP-6 effects on bone formation. Endocrinology 1998, 139:5125-5134.
17. Sangadala S., Boden S.D., Metpally R.P., Reddy B.V. Modeling and analysis of molecularinteraction between Smurf1-WW2 domain and various isoforms of LIM mineralization protein. Proteins 2007, 68:690-701.
18. Suh J.S., Lee J.Y., Choi Y.S., Yu F., Yang V., Lee S.J., et al. Efficient labeling of mesenchymal stem cells using cell permeable magnetic nanoparticles. Biochem Biophys Res Commun 2009, 379:669-675.
19. Ahmed A.S., Li J., Ahmed M., Hua L., Yakovleva T., Ossipov M.H., et al. Attenuation of pain and inflammation in adjuvant-induced arthritis by the proteasome inhibitor MG132. Arthritis Rheum 2010, 62:2160-2169.
20. Guo R., Yamashita M., Zhang Q., Zhou Q., Chen D., Reynolds D.G., et al. Ubiquitin ligase Smurf1 mediates tumor necrosis factor-induced systemic bone loss by promoting proteasomal degradation of bone morphogenetic signaling proteins. JBiol Chem 2008, 283:23084-23092.
21. Hanyu A., Ishidou Y., Ebisawa T., Shimanuki T., Imamura T., Miyazono K. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling. JCell Biol 2001, 155:1017-1027.
22. Ito Y., Bringas P., Mogharei A., Zhao J., Deng C., Chai Y. Receptor-regulated and inhibitory Smads are critical in regulating transforming growth factor beta-mediated Meckel's cartilage development. Dev Dyn 2002, 224:69-78.
23. Wunder A., Tung C.H., Muller-Ladner U., Weissleder R., Mahmood U. Invivo imaging of protease activity in arthritis: a novel approach for monitoring treatment response. Arthritis Rheum 2004, 50:2459-2465.
24. Lee K.S., Kim H.J., Li Q.L., Chi X.Z., Ueta C., Komori T., et al. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 2000, 20:8783-8792.
25. Gompels L.L., Madden L., Lim N.H., Inglis J.J., McConnell E., Vincent T.L., et al. Invivo fluorescence imaging of E-selectin: quantitative detection of endothelial activation in a mouse model of arthritis. Arthritis Rheum 2011, 63:107-117.
26. Oh J.Y., Kim M.K., Shin M.S., Wee W.R., Lee J.H. Cytokine secretion by human mesenchymal stem cells cocultured with damaged corneal epithelial cells. Cytokine 2009, 46:100-103.
27. Liao E.Y., Liao H.J., Guo L.J., Zhou H.D., Wu X.P., Dai R.C., et al. Membrane-type matrix metalloproteinase-1 (MT1-MMP) is down-regulated in estrogen-deficient rat osteoblast invivo. JEndocrinol Invest 2004, 27:1-5.
28. Niki Y., Takeuchi T., Nakayama M., Nagasawa H., Kurasawa T., Yamada H., et al. Clinical significance of cartilage biomarkers for monitoring structural joint damage in rheumatoid arthritis patients treated with anti-TNF therapy. PLoS One 2012, 7:e37447.
29. Amiable N., Tat S.K., Lajeunesse D., Duval N., Pelletier J.P., Martel-Pelletier J., et al. Proteinase-activated receptor (PAR)-2 activation impacts bone resorptive properties of human osteoarthritic subchondral bone osteoblasts. Bone 2009, 44:1143-1150.
30. Pauling L., Corey R.B., Branson H.R. The structure of proteins; two hydrogen-bonded helical configurations of the polypeptide chain. Proc Natl Acad Sci U S A 1951, 37(4):205-211.
31. Campbell R.E. Fluorescent-protein-based biosensors: modulation of energy transfer as a design principle. Anal Chem 2009, 1(81):5972-5979.
32. Park Y.J., Chang L.C., Liang J.F., Moon C., Chung C.P., Yang V.C. Nontoxic membrane translocation peptide from protamine, low molecular weight protamine (LMWP), for enhanced intracellular protein delivery: invitro and invivo study. FASEB J 2005, 19:1555-1557.
33. Choi Y.S., Lee J.Y., Suh J.S., Kwon Y.M., Lee S.J., Chung J.K., et al. The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine. Biomaterials 2010, 31:1429-1443.
34. Hung C.F., Lu K.C., Cheng T.L., Wu R.H., Huang L.Y., Teng C.F., et al. Anovel siRNAvalidation system for functional screening and identification of effective RNAi probes in mammalian cells. Biochem Biophys Res Commun 2006, 346:707-720.
35. Tung C.H., Mueller S., Weissleder R. Novel branching membrane translocational peptide as gene delivery vector. Bioorg Med Chem 2002, 10:3609-3614.
36. Choi Y.J., Lee J.Y., Park J.H., Park J.B., Suh J.S., Choi Y.S., et al. The identification of a heparin binding domain peptide from bone morphogenetic protein-4 and its role on osteogenesis. Biomaterials 2010, 31:7226-7238.
37. Cao J., Wan S., Tian J., Li S., Deng D., Qian Z., et al. Fast clearing RGD-based near-infrared fluorescent probes for invivo tumor diagnosis. Contrast Media Mol Imaging 2012, 7:390-402.
38. Tang C.H., Yang R.S., Liou H.C., Fu W.M. Enhancement of fibronectin synthesis and fibrillogenesis by BMP-4 in cultured rat osteoblast. JBone Miner Res 2003, 18:502-511.
39. van der Horst G., van Bezooijen R.L., Deckers M.M., Hoogendam J., Visser A., Lowik C.W., et al. Differentiation of murine preosteoblastic KS483 cells depends on autocrine bone morphogenetic protein signaling during all phases of osteoblast formation. Bone 2002, 31:661-669.
40. Edgar C.M., Chakravarthy V., Barnes G., Kakar S., Gerstenfeld L.C., Einhorn T.A. Autogenous regulation of a network of bone morphogenetic proteins (BMPs) mediates the osteogenic differentiation in murine marrow stromal cells. Bone 2007, 40:1389-1398.
41. Sammons J., Ahmed N., El-Sheemy M., Hassan H.T. The role of BMP-6, IL-6, and BMP-4 in mesenchymal stem cell-dependent bone development: effects on osteoblastic differentiation induced by parathyroid hormone and vitamin D(3). Stem Cells Dev 2004, 13:273-280.